- Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma
-
Scandurra , Scibilia G, Banna GL, D'Agate G, Lipari H, Gieri S, Scollo P
- KMID: 2160794
- J Gynecol Oncol.
- 2015 Apr;26(2):118-124.
- doi: 10.3802/jgo.2015.26.2.118
OBJECTIVE: To evaluate the efficacy and tolerability of a neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy in patients with locally advanced cervical carcinoma. METHODS: Patients with histologically confirmed locally advanced cervical carcinoma,... -
- CITED
-
- Close
- SHARE
-
- Close
- Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
-
Han HS, Kim JS, Park JH, Jeon YK, Lee KW, Oh DY, Kim JH, Park SY, Im SA, Kim TY, Park IA, Bang YJ
- KMID: 1782015
- J Korean Med Sci.
- 2009 Oct;24(5):910-917.
- doi: 10.3346/jkms.2009.24.5.910
We evaluated the efficacy and safety of weekly paclitaxel plus trastuzumab as firs-tline chemotherapy in women with HER2-overexpressing metastatic breast cancer (MBC), and we investigated the prognostic factors including magnitude... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparisons of the Effects of Stent Eccentricity on the Neointimal Hyperplasia between Sirolimus-Eluting Stent versus Paclitaxel-Eluting Stent
-
Kim BK, Ko YG, Oh S, Kim JS, Kang WC, Jeon DW, Yang JY, Choi D, Hong MK, Ahn T, Jang Y
- KMID: 1779626
- Yonsei Med J.
- 2010 Nov;51(6):823-831.
- doi: 10.3349/ymj.2010.51.6.823
PURPOSE: Previous studies suggested that asymmetric stent expansion did not affect suppression of neointimal hyperplasia (NIH) after sirolimus-eluting stents (SES) implantation. The aim of this study was to evaluate the... -
- CITED
-
- Close
- SHARE
-
- Close
- An open-label, multicenter, phase I trial of a cremophor-free, polymeric micelle formulation of paclitaxel combined with carboplatin as a first-line treatment for advanced ovarian cancer: a Korean Gynecologic Oncology Group study (KGOG-3016)
-
Lee SW, Kim YM, Kim YT, Kang SB
- KMID: 2413442
- J Gynecol Oncol.
- 2017 May;28(3):e26.
- doi: 10.3802/jgo.2017.28.e26
OBJECTIVE: This phase I study aimed to determine the maximum tolerated dose (MTD) of Genexol-PM, when combined with carboplatin, as a first-line treatment in patients with advanced ovarian cancer. METHODS: This... -
- CITED
-
- Close
- SHARE
-
- Close
- Serial Morphological Changes of Side-Branch Ostium after Paclitaxel-Coated Balloon Treatment of De Novo Coronary Lesions of Main Vessels
-
Her AY, Ann SH, Singh GB, Kim YH, Okamura T, Garg S, Koo BK, Shin ES
- KMID: 2374078
- Yonsei Med J.
- 2016 May;57(3):606-613.
- doi: 10.3349/ymj.2016.57.3.606
PURPOSE: The effects on the side-branch (SB) ostium, following paclitaxel-coated balloon (PCB) treatment of de novo coronary lesions of main vessels have not been previously investigated. This study was aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Sirolimus and Paclitaxel-Eluting Stents for Complex Coronary Lesions: An Intravascular Ultrasound Study
-
Cho YK, Hur SH, Kim HT, Kim IC, Park HS, Yoon HJ, Nam CW, Kim H, Han SW, Kim YN, Kim KB
- KMID: 1776660
- Korean J Intern Med.
- 2009 Dec;24(4):323-329.
- doi: 10.3904/kjim.2009.24.4.323
BACKGROUND/AIMS: Recent intravascular ultrasound (IVUS) studies of sirolimus-eluting stents (SES) and paclitaxel-eluting stents (PES) have demonstrated a significant reduction in neointimal hyperplasia (NIH) based on simple coronary lesions. In this... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy of a Multiplex Paclitaxel Emission Stent Using a Pluronic® Mixture Membrane versus a Covered Metal Stent in Malignant Biliary Obstruction: A Prospective Randomized Comparative Study
-
Jang SI, Lee SJ, Jeong S, Lee DH, Kim MH, Yoon HJ, Lee DK
- KMID: 2412238
- Gut Liver.
- 2017 Jul;11(4):567-573.
- doi: 10.5009/gnl16428
BACKGROUND/AIMS: A drug-eluting stent for unresectable malignant biliary obstruction was developed to increase stent patency by preventing tumor ingrowth. The safety and efficacy of a new generation of metallic stents... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
-
Kwon JS, Park RK, Shim TJ, Jeong MH, Cho MC, Ahn Y, Kim DW
- KMID: 1106556
- J Vet Sci.
- 2011 Jun;12(2):143-149.
- doi: 10.4142/jvs.2011.12.2.143
The purpose of our study was to create a novel rat aorta stent implantation model. Stainless steel bare metal stents (BMS) or paclitaxel-eluting stents (PES) were implanted in male Sprague-Dawley... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
-
Her AY, Ann SH, Singh GB, Kim YH, Yoo SY, Garg S, Koo BK, Shin ES
- KMID: 2374037
- Yonsei Med J.
- 2016 Mar;57(2):337-341.
- doi: 10.3349/ymj.2016.57.2.337
PURPOSE: This study compared the angiographic outcomes of paclitaxel-coated balloon (PCB) versus plain old balloon angioplasty (POBA) treatment for de novo coronary artery lesions. At present, there is no available... -
- CITED
-
- Close
- SHARE
-
- Close
- Two-year Clinical Outcomes of Patients with Long Segments Drug-Eluting Stents: Comparison of Sirolimus-Eluting Stent with Paclitaxel-Eluting Stent
-
Kim U, Lee SH, Hong GR, Park JS, Shin DG, Kim YJ, Jang JS, Yang TH, Kim DK, Kim DS, Kim DK, Seol SH, Kim DI, Cho YK, Kim HS, Nam CW, Hur SH, Kim KB
- KMID: 1785986
- J Korean Med Sci.
- 2011 Oct;26(10):1299-1304.
- doi: 10.3346/jkms.2011.26.10.1299
Limited data are available on the long-term clinical efficacy of drug-eluting stent (DES) in diffuse long lesions. From May 2006 to May 2007, a total of 335 consecutive patients (374... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical outcomes between different stent designs with the same polymer and drug: comparison between the Taxus Express and Taxus Liberte stents
-
Son JW, Kim U, Park JS, Kim YJ, Jang JS, Yang TH, Kim DS, Kim DK, Seol SH, Kim DI, Nam CW, Hur SH, Kim KB
- KMID: 1793221
- Korean J Intern Med.
- 2013 Jan;28(1):72-80.
- doi: 10.3904/kjim.2013.28.1.72
BACKGROUND/AIMS: The Taxus Liberte stent (Boston Scientific Co.) evolved from the Taxus Express stent, with enhanced stent deliverability and uniform drug delivery. This study was designed to compare angiographic and... -
- CITED
-
- Close
- SHARE
-
- Close
